Legal Documents

Apr 12, 2021
The Centers for Medicare & Medicaid Services’ Hospital Price Transparency final rule goes into effect on Jan. 1, 2021. The AHA and three other national organizations sued the federal government challenging the final rule. The case is pending in a federal appeals court.
Apr 4, 2022
The federal government tells the court it anticipates issuing a final rule by early this summer, which is later than the May time period it had been expected.
Apr 4, 2022
The AHA and American Medical Association urge the U.S. District Court for the District of Columbia to act as quickly as possible to hold unlawful and vacate all provisions they are challenging in the federal government’s interim final rule on surprise medical billing, which took effect in January.
Mar 30, 2022
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
Mar 30, 2022
AHA v Becerra March 2022 Medicare Appeals Dashboard
Dec 9, 2021
Plaintiffs American Medical Association (“AMA”), American Hospital Association (“AHA”), Renown Health, UMass Memorial Health Care, Inc. (“UMass Memorial Health”), Stuart S. Squires, M.D., and Victor F. Kubit, M.D., by and through their attorneys, bring this action for declaratory and injunctive…
Nov 20, 2021
The government does not dispute that the agency singled out Section 340B hospitals as a group and set their reimbursement based on acquisition cost rather than price, without conducting the cost study that the statute requires. The agency’s action was therefore contrary to law.
Nov 5, 2021
ORDERED that the plaintiffs' Motions for Summary Judgment, Dkt. 19 (Novartis), Dkt. 14 (United Therapeutics) are GRANTED IN PART and DENIED IN PART.
Nov 5, 2021
This case concerns conditions that plaintiffs Novartis Pharmaceuticals Corporation and United Therapeutics Corporation have imposed on discounted drug purchases by certain safetynet health care providers.